Clinical Trial Update: Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating benefit/risk of Insuman Implantable versus Insuplant using a Medtronic implantable pump in adults with Type 1 diabetes; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insuman Implantable (insulin)
• Insuplant (insulin)
• Medtronic MiniMed Implantable Pump System

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED